ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Study of Breast Cancer On Long Island

June 17, 1994

HHS To Award “Micro-Grants” For Public Health Programs.

July 20, 2001

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

An Alliance of NSABP-RTOG And GOG?

March 25, 2011